特宝生物
(688278)
| 流通市值：334.88亿 | | | 总市值：334.88亿 |
| 流通股本：4.07亿 | | | 总股本：4.07亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,510,615,117.77 | 673,345,118.05 | 2,817,158,242.24 | 1,954,701,664.76 |
| 营业收入 | 1,510,615,117.77 | 673,345,118.05 | 2,817,158,242.24 | 1,954,701,664.76 |
| 二、营业总成本 | 1,025,083,005.41 | 460,732,480.5 | 1,881,373,801.84 | 1,299,117,116.43 |
| 营业成本 | 106,031,437.95 | 45,964,557.21 | 183,510,989.26 | 129,931,313.61 |
| 税金及附加 | 7,638,447.31 | 3,447,135.69 | 13,734,839.56 | 9,607,337.31 |
| 销售费用 | 598,906,025.59 | 279,057,633.19 | 1,113,261,379.3 | 777,951,300.68 |
| 管理费用 | 140,327,604.73 | 67,371,305.32 | 278,335,096.01 | 190,145,563.47 |
| 研发费用 | 174,802,367.14 | 66,748,824.3 | 294,706,975.17 | 193,341,950.18 |
| 财务费用 | -2,622,877.31 | -1,856,975.21 | -2,175,477.46 | -1,860,348.82 |
| 其中:利息费用 | 379,937.93 | 117,669.02 | 452,682.01 | 357,362.06 |
| 其中:利息收入 | 2,896,353.29 | 1,959,565.87 | 2,940,756.94 | 2,329,579.68 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 590,535.23 | 40,457.03 | 882,868.15 | 1,293,715.4 |
| 加:投资收益 | 1,873,297.19 | 1,354,606.79 | 4,053,394.38 | 2,283,996.64 |
| 资产处置收益 | 14,090.2 | 10,027.68 | 65,368.15 | 45,498.08 |
| 信用减值损失(新) | 986,036.52 | 779,811.54 | -3,608,425.93 | -547,467.37 |
| 其他收益 | 8,153,402.56 | 5,167,341.68 | 33,558,945.95 | 14,285,614.94 |
| 四、营业利润 | 497,149,474.06 | 219,964,882.27 | 970,736,591.1 | 672,945,906.02 |
| 加:营业外收入 | 598,955.94 | 229,195.89 | 682,275.72 | 641,065.38 |
| 减:营业外支出 | 21,476,326.28 | 10,977,891 | 40,392,302.79 | 27,835,028.99 |
| 五、利润总额 | 476,272,103.72 | 209,216,187.16 | 931,026,564.03 | 645,751,942.41 |
| 减:所得税费用 | 48,377,992.51 | 27,087,270.27 | 103,424,330.14 | 91,602,724.6 |
| 六、净利润 | 427,894,111.21 | 182,128,916.89 | 827,602,233.89 | 554,149,217.81 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 427,894,111.21 | 182,128,916.89 | 827,602,233.89 | 554,149,217.81 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 427,894,111.21 | 182,128,916.89 | 827,602,233.89 | 554,149,217.81 |
| 扣除非经常损益后的净利润 | 431,339,041.81 | 188,596,287.25 | 826,964,773.08 | 580,667,315.81 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 1.05 | 0.45 | 2.03 | 1.36 |
| (二)稀释每股收益 | 1.05 | 0.45 | 2.03 | 1.36 |
| 九、综合收益总额 | 427,894,111.21 | 182,128,916.89 | 827,602,233.89 | 554,149,217.81 |
| 归属于母公司股东的综合收益总额 | 427,894,111.21 | 182,128,916.89 | 827,602,233.89 | 554,149,217.81 |
| 公告日期 | 2025-08-21 | 2025-04-23 | 2025-03-28 | 2024-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |